Showing results (1571-1580 of 2,143) with videos related to

Sort By:
Pageof 215
Pharmaceuticals (Basel, Switzerland)|May 22, 2019
Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma TreatmentSami A Makharza, Giuseppe Cirillo, Orazio Vittorio, et al.
Molecular Medicine (Cambridge, Mass.)|June 2, 2011
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's diseaseJeremy Koppel, Fabien Campagne, Valérie Vingtdeux, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 23, 2002
Self-assembly of tetrahedral and trigonal antiprismatic clusters [Fe4(L4)4] and [Fe6(L5)6] on the basis of trigonal tris-bidentate chelatorsRolf W Saalfrank, Horst Glaser, Bernhard Demleitner, et al.
Nature Genetics|May 1, 1996
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerS Neuhausen, T Gilewski, L Norton, et al.
The Journal of Nervous and Mental Disease|March 30, 2012
Patterns of autobiographical memory in bipolar disorder examined by psychometric and functional neuroimaging methodsViola Oertel-Knöchel, Britta Reinke, Alexandra Hornung, et al.
European Journal of Nutrition|May 9, 2022
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B12 status among young Laotian children: a randomized controlled trialGuy-Marino Hinnouho, Daniela Hampel, Setareh Shahab-Ferdows, et al.
Current Neuropharmacology|December 2, 2021
Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway ModelHarald Hampel, Giuseppe Caruso, Robert Nisticò, et al.
Gastroenterology|January 10, 2022
Prevalence and Predictors of Young-Onset Colorectal Neoplasia: Insights From a Nationally Representative Colonoscopy RegistryParth D Trivedi, Aditi Mohapatra, Melissa K Morris, et al.
Schmerz (Berlin, Germany)|September 7, 2006
[Pain therapy in addicted patients]C Hampel, M Schenk, H Göbel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 23, 2019
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's diseaseAndrea Vergallo, Lucile Mégret, Simone Lista, et al.
Pageof 215